ASKA Pharmaceutical Holdings CO., Ltd.【JP:4886】Cash flow
Market cap
¥60.4B
P/E ratio
11.9x
| 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 2,885 | 3,127 | 2,662 | 2,247 |
| Cash from operations | 2,842 | 3,351 | 1,486 | 2,485 |
| Capital expenditures | -579 | -461 | -1,320 | -2,960 |
| Cash from investing | 6,743 | -1,126 | 1,706 | -6,124 |
| Payments for dividends | -398 | -452 | -792 | -1,275 |
| Proceeds from issuance of term debt, net | - | - | - | 3,000 |
| Repayments of term debt | -2,298 | -1,423 | -3,138 | -4,680 |
| Cash from financing | -2,996 | -1,820 | -3,943 | -2,956 |